Cytokine action and oxidative stress response in differentiated neuroblastoma SH-SY5Y cells

Acta Biochim Pol. 2003;50(3):659-66.

Abstract

In the retinoic acid-differentiated neuroblastoma SH-SY5Y cells, IL-1 induced binding activity of NFkappaB and up-regulated the expression and activity of MnSOD. The IL-1-elicited effects were partly reversed by IL-4 and IL-6. It is proposed that IL-4 and IL-6 may participate in the regulation of the imbalanced oxidant status induced by IL-1 in differentiated neuroblastoma cells. In the SH-SY5Y cell line, TNFalpha neither activated NFkappaB nor induced MnSOD expression and activity, but was capable of modulating the IL-1 effects. Pyrrolidine dithiocarbamate (PDTC), an inhibitor of NFkappaB activation, down-regulated the expression and activity of MnSOD, which may suggest that the regulation of MnSOD by IL-1 in retinoic acid-differentiated neuroblastoma cells was mediated by the nuclear factor kappaB.

MeSH terms

  • Brain Neoplasms / metabolism*
  • Cell Differentiation / drug effects
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation / drug effects
  • Humans
  • Interleukin-1 / pharmacology
  • Interleukin-4 / pharmacology
  • Interleukin-6 / pharmacology
  • NF-kappa B / metabolism*
  • Neuroblastoma / metabolism*
  • Oxidative Stress / drug effects*
  • Proline / analogs & derivatives*
  • Proline / pharmacology
  • Protein Binding / drug effects
  • Superoxide Dismutase / metabolism*
  • Thiocarbamates / pharmacology
  • Tretinoin / pharmacology
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Enzyme Inhibitors
  • Interleukin-1
  • Interleukin-6
  • NF-kappa B
  • Thiocarbamates
  • Tumor Necrosis Factor-alpha
  • prolinedithiocarbamate
  • Interleukin-4
  • Tretinoin
  • Proline
  • Superoxide Dismutase